what is retatrutide good for Buy in the UK Retatrutide UK 2026: Phase 3

(Source: In August 2025 , Viking Therapeutic announced encouraging mid-stage trial results for its experimental oral/injectable weight loss drug VK2735, which achieved up to 12.2% body weight reduction over 12 weeks, through shares dropped due to higher treatment discontinuation from gastrointestinal side effects

This raises theoretical concerns about affecting levothyroxine absorption, though the evidence is less definitive than with oral semaglutide

Why most researchers prefer 2ml Three reasons keep coming up consistently

Diabetes Obes Metab 22:938946

62.9% of patients achieved more than 20% weight loss compared to 1.3% on lifestyle changes alone